Human obesity susceptibility gene and uses thereof
CA 2484176 A1 · Owner: Hager, Joerg · Inventors: Roschmann, Elke; Brooks, Peter; Hager, Joerg
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention discloses the identification of a human obesity susceptibility gene; which can be used for the diagnosis prevention and , treatment of obesity and related disorders as well as for the screening of , therapeutically active drugs. The invention more specifically discloses that the PPYR1 gene on chromosome 10 and certain alleles thereof are related to susceptibility to obesity and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the PPYRl gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.